PROGRAMMED CELL DEATH 1 LIGAND 1 EXPRESSION AND ASSOCIATION WITH SURVIVAL IN MESOTHELIOMA

被引：0
|
作者：
Mansfield, A. S. [1 ]
Peikert, T. [1 ]
Roden, A. [1 ]
Krco, C. [1 ]
Harrington, S. [1 ]
Dong, H. [1 ]
Kwon, E. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
127O
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [41] Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability
    Cho, Junhun
    Lee, Jeeyun
    Bang, Heejin
    Kim, Seung Tae
    Park, Se Hoon
    An, Ji Yeong
    Choi, Min Gew
    Lee, Joon Ho
    Sohn, Tae Sung
    Bae, Jae Moon
    Kang, Won Ki
    Kim, Sung
    Kim, Kyoung-Mee
    ONCOTARGET, 2017, 8 (08) : 13320 - 13328
  • [42] Programmed Death Ligand 1 Expression in Laryngeal Squamous Cell Carcinomas and Prognosis
    Batur, Sebnem
    Kain, Zeynep Ecem
    Gozen, Emine Deniz
    Kepil, Nuray
    Aydin, Ovgu
    Comunoglu, Nil
    CLINICAL PATHOLOGY, 2020, 13
  • [43] Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications
    Wolkow, Natalie
    Jakobiec, Frederick A.
    Afrogheh, Amir H.
    Eagle, Ralph C., Jr.
    Pai, Sara, I
    Faquin, William C.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 200 : 226 - 241
  • [44] Heterogeneity of programmed cell death-ligand 1 expression in lung cancer
    Mansfield, Aaron
    Murphy, Stephen
    Peikert, Tobias
    Vasmatzis, George
    Wigle, Dennis
    Aubry, Marie Christine
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S31 - S32
  • [45] Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
    Droeser, Raoul A.
    Hirt, Christian
    Viehl, Carsten T.
    Frey, Daniel M.
    Nebiker, Christian
    Huber, Xaver
    Zlobec, Inti
    Eppenberger-Castori, Serenella
    Tzankov, Alexander
    Rosso, Raffaele
    Zuber, Markus
    Muraro, Manuele Giuseppe
    Amicarella, Francesca
    Cremonesi, Eleonora
    Heberer, Michael
    Iezzi, Giandomenica
    Lugli, Alessandro
    Terracciano, Luigi
    Sconocchia, Giuseppe
    Oertli, Daniel
    Spagnoli, Giulio C.
    Tornillo, Luigi
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (09) : 2233 - 2242
  • [46] The significance of programmed cell death ligand 1 expression in resected lung adenocarcinoma
    Wu, Shafei
    Shi, Xiaohua
    Sun, Jian
    Liu, Yuanyuan
    Luo, Yufeng
    Liang, Zhiyong
    Wang, Jinghui
    Zeng, Xuan
    ONCOTARGET, 2017, 8 (10) : 16421 - 16429
  • [47] Heterogeneity of Programmed Cell Death Ligand 1 Expression in Multifocal Lung Cancer
    Mansfield, Aaron S.
    Murphy, Stephen J.
    Peikert, Tobias
    Yi, Eunhee S.
    Vasmatzis, George
    Wigle, Dennis A.
    Aubry, Marie Christine
    CLINICAL CANCER RESEARCH, 2016, 22 (09) : 2177 - 2182
  • [48] Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
    Chen, Kaiyan
    Cheng, Guoping
    Zhang, Fanrong
    Zhang, Nan
    Li, Dan
    Jin, Jiaoyue
    Wu, Junzhou
    Ying, Lisha
    Mao, Weimin
    Su, Dan
    ONCOTARGET, 2016, 7 (21) : 30772 - 30780
  • [49] Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1
    Lee, Joo Sang
    Ruppin, Eytan
    JAMA ONCOLOGY, 2019, 5 (11) : 1614 - 1618
  • [50] Programmed death 1 Ligand 1 expression in breast cancer and its association with patients' clinical parameters
    Li, Fei
    Ren, Yi
    Wang, Zhandong
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (01) : 150 - 154
12345